145 related articles for article (PubMed ID: 25755775)
1. In situ hybridization analysis of the expression of miR-106b in colonic cancer.
Wang YX; Lang F; Liu YX; Yang CQ; Gao HJ
Int J Clin Exp Pathol; 2015; 8(1):786-92. PubMed ID: 25755775
[TBL] [Abstract][Full Text] [Related]
2. Initial study of microRNA expression profiles of colonic cancer without lymph node metastasis.
Wang YX; Zhang XY; Zhang BF; Yang CQ; Chen XM; Gao HJ
J Dig Dis; 2010 Feb; 11(1):50-4. PubMed ID: 20132431
[TBL] [Abstract][Full Text] [Related]
3. Increased expression of microRNA-150 is associated with poor prognosis in non-small cell lung cancer.
Yin QW; Sun XF; Yang GT; Li XB; Wu MS; Zhao J
Int J Clin Exp Pathol; 2015; 8(1):842-6. PubMed ID: 25755784
[TBL] [Abstract][Full Text] [Related]
4. Expression of microRNA-106b and its clinical significance in cutaneous melanoma.
Lin N; Zhou Y; Lian X; Tu Y
Genet Mol Res; 2015 Dec; 14(4):16379-85. PubMed ID: 26662433
[TBL] [Abstract][Full Text] [Related]
5. Identifying High-Risk Stage II Colon Cancer Patients: A Three-MicroRNA-Based Score as a Prognostic Biomarker.
Caritg O; Navarro A; Moreno I; Martínez-Rodenas F; Cordeiro A; Muñoz C; Ruiz-Martinez M; Santasusagna S; Castellano JJ; Monzó M
Clin Colorectal Cancer; 2016 Dec; 15(4):e175-e182. PubMed ID: 27247088
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of microRNA-93 downregulation in human colon cancer.
Xiao ZG; Deng ZS; Zhang YD; Zhang Y; Huang ZC
Eur J Gastroenterol Hepatol; 2013 Mar; 25(3):296-301. PubMed ID: 23354160
[TBL] [Abstract][Full Text] [Related]
7. Correlation between microRNA-421 expression level and prognosis of gastric cancer.
Liu H; Gao Y; Song D; Liu T; Feng Y
Int J Clin Exp Pathol; 2015; 8(11):15128-32. PubMed ID: 26823855
[TBL] [Abstract][Full Text] [Related]
8. Sequential expression of miR-182 and miR-503 cooperatively targets FBXW7, contributing to the malignant transformation of colon adenoma to adenocarcinoma.
Li L; Sarver AL; Khatri R; Hajeri PB; Kamenev I; French AJ; Thibodeau SN; Steer CJ; Subramanian S
J Pathol; 2014 Dec; 234(4):488-501. PubMed ID: 25269767
[TBL] [Abstract][Full Text] [Related]
9. Abnormal expression of miR-1 in breast carcinoma as a potent prognostic factor.
Minemura H; Takagi K; Miki Y; Shibahara Y; Nakagawa S; Ebata A; Watanabe M; Ishida T; Sasano H; Suzuki T
Cancer Sci; 2015 Nov; 106(11):1642-50. PubMed ID: 26331797
[TBL] [Abstract][Full Text] [Related]
10. Specific microRNAs as novel biomarkers for combination chemotherapy resistance detection of colon adenocarcinoma.
Hu J; Xu Y; Cai S
Eur J Med Res; 2015 Dec; 20():95. PubMed ID: 26626874
[TBL] [Abstract][Full Text] [Related]
11. Associations of high expression of miR-106b-5p detected from FFPE sample with poor prognosis of RCC patients.
Liu K; Pan X; Peng X; Zhang C; Li H; Guan X; Xu W; Xu J; Zhao L; Wang T; Lai Y
Pathol Res Pract; 2019 Jun; 215(6):152391. PubMed ID: 31076282
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of microRNA-183 in human colorectal cancer and its clinical significance.
Zhou T; Zhang GJ; Zhou H; Xiao HX; Li Y
Eur J Gastroenterol Hepatol; 2014 Feb; 26(2):229-33. PubMed ID: 24150523
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA expression profile in non-cancerous colonic tissue associated with lymph node metastasis of colon cancer.
Huang ZM; Yang J; Shen XY; Zhang XY; Meng FS; Xu JT; Zhang BF; Gao HJ
J Dig Dis; 2009 Aug; 10(3):188-94. PubMed ID: 19659786
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma.
Schetter AJ; Leung SY; Sohn JJ; Zanetti KA; Bowman ED; Yanaihara N; Yuen ST; Chan TL; Kwong DL; Au GK; Liu CG; Calin GA; Croce CM; Harris CC
JAMA; 2008 Jan; 299(4):425-36. PubMed ID: 18230780
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of miR-106b expression in breast cancer patients.
Zheng R; Pan L; Gao J; Ye X; Chen L; Zhang X; Tang W; Zheng W
J Surg Res; 2015 May; 195(1):158-65. PubMed ID: 25619461
[TBL] [Abstract][Full Text] [Related]
16. MiR-27 as a prognostic marker for breast cancer progression and patient survival.
Tang W; Zhu J; Su S; Wu W; Liu Q; Su F; Yu F
PLoS One; 2012; 7(12):e51702. PubMed ID: 23240057
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of 5-microRNA based signature in T2-T3N0 colon cancer.
Bobowicz M; Skrzypski M; Czapiewski P; Marczyk M; Maciejewska A; Jankowski M; Szulgo-Paczkowska A; Zegarski W; Pawłowski R; Polańska J; Biernat W; Jaśkiewicz J; Jassem J
Clin Exp Metastasis; 2016 Dec; 33(8):765-773. PubMed ID: 27485175
[TBL] [Abstract][Full Text] [Related]
18. microRNA-451 regulates macrophage migration inhibitory factor production and proliferation of gastrointestinal cancer cells.
Bandres E; Bitarte N; Arias F; Agorreta J; Fortes P; Agirre X; Zarate R; Diaz-Gonzalez JA; Ramirez N; Sola JJ; Jimenez P; Rodriguez J; Garcia-Foncillas J
Clin Cancer Res; 2009 Apr; 15(7):2281-90. PubMed ID: 19318487
[TBL] [Abstract][Full Text] [Related]
19. Up-regulation of miR-9 expression predicate advanced clinicopathological features and poor prognosis in patients with hepatocellular carcinoma.
Cai L; Cai X
Diagn Pathol; 2014 Dec; 9():1000. PubMed ID: 25552204
[TBL] [Abstract][Full Text] [Related]
20. Validation of expression patterns for nine miRNAs in 204 lymph-node negative breast cancers.
Jonsdottir K; Janssen SR; Da Rosa FC; Gudlaugsson E; Skaland I; Baak JP; Janssen EA
PLoS One; 2012; 7(11):e48692. PubMed ID: 23144930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]